Copay assistance fund status, eligibility, and covered drugs — for patient access and billing teams.
Maximum award Up to $8,000 per 12-month grant period · Income ≤500% FPL, adjusted for household size and regional cost of living · Prescription drug copayments and Medicare Part B insurance premiums for hyperoxaluria treatments including allopurinol, lumasiran, nedosiran, oxlumo, and potassium citrate.
Published terms from the foundation. Per-patient eligibility and amounts are confirmed at application.
E72.530 E72.538Drugs whose J-codes this fund matches. Each links to its billing & coding reference.
Also matches J-codes not yet in our drug library: J3480
The foundation's own covered-medication list for this fund (5 drugs). Confirm coverage of your exact NDC at application.
Fund status changes with donations, often without an announcement — confirm directly with the foundation at 800-675-8416, and check the alternatives below.
As of June 10, 2026, the HealthWell Foundation Hyperoxaluria fund is OPEN and accepting applications. Verify at time of service: 800-675-8416.
Up to $8,000 per 12-month grant period. Prescription drug copayments and Medicare Part B insurance premiums for hyperoxaluria treatments including allopurinol, lumasiran, nedosiran, oxlumo, and potassium citrate.
Household income must be ≤500% FPL, adjusted for household size and regional cost of living. Treatment must occur within the United States.
Accepted: commercial, medicare, medicaid.